DAFNA Capital Management’s Palvella Therapeutics PVLA Stock Holding History

DAFNA Capital Management’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-43,348	Closed	-$977K	–	83
2025 Q2	$977K	Hold	43,348	–	–	0.27%	58
2025 Q1	$1.21M	Sell	43,348 -28,104	-39%	-$542K	0.34%	50
2024 Q4	$857K	Buy	+71,452	New	+$1.12M	0.22%	64
2017 Q2	–	Sell	-669	Closed	-$139K	–	79
2017 Q1	$139K	Sell	669 -2,123	-76%	-$376K	0.12%	67
2016 Q4	$314K	Hold	2,792	–	–	0.28%	57
2016 Q3	$408K	Hold	2,792	–	–	0.28%	59
2016 Q2	$360K	Buy	2,792 +2,164	+345%	+$332K	0.29%	66
2016 Q1	$95K	Buy	+628	New	+$88.3K	0.08%	83
2015 Q3	–	Sell	-1,563	Closed	-$344K	–	92
2015 Q2	$344K	Buy	+1,563	New	+$344K	0.29%	59

Other funds holding PVLA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return